amsacrine has been researched along with Lymphoma, B-Cell in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vorob'ev, VI | 1 |
| Vorob'ev, IA | 1 |
| Lorie, IuIu | 1 |
| Zvonkov, EE | 1 |
| Kremenetskaia, AM | 1 |
| Obukhova, TN | 1 |
| Kravchenko, SK | 1 |
1 other study available for amsacrine and Lymphoma, B-Cell
| Article | Year |
|---|---|
[A case of unclassified B-cell lymphosarcoma].
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cytarabine; Diagnosis, Differenti | 2008 |